ro 31-8220 has been researched along with Cardiomyopathy, Congestive in 1 studies
Ro 31-8220: a protein kinase C inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hambleton, M | 1 |
| Hahn, H | 1 |
| Pleger, ST | 1 |
| Kuhn, MC | 1 |
| Klevitsky, R | 1 |
| Carr, AN | 1 |
| Kimball, TF | 1 |
| Hewett, TE | 1 |
| Dorn, GW | 1 |
| Koch, WJ | 1 |
| Molkentin, JD | 1 |
1 other study available for ro 31-8220 and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure.
Topics: Animals; Calcium; Cardiac Output, Low; Cardiomyopathy, Dilated; DNA; Enzyme Activation; Female; Gene | 2006 |